Current understanding of precursors to pancreatic cancer

被引:41
|
作者
Takaori, Kyoichi [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Osaka 5698686, Japan
来源
关键词
PanIN (pancreatic intraepithelial neoplasia); IPMN (intraductal papillary mucinous neoplasm); MCN (mucinous cystic neoplasm); carcinoma in situ; carcinogenesis;
D O I
10.1007/s00534-006-1165-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Precursors to pancreatic cancer have been investigated for a century. Previous studies have revealed three distinct precursors, i.e. mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN), and pancreatic intraepithelial neoplasia (PanIN), harboring identical or similar genetic alterations as does invasive pancreatic carcinoma. The current understanding of precursors to pancreatic cancer can be illustrated by progressive pathways from noninvasive MCN, IPMN, and PanIN toward invasive carcinoma. MCNs consist of ovarian-type stroma and epithelial lining with varying grades of atypia, and are occasionally associated with invasive adenocarcinoma. The epithelium of noninvasive IPMNs shows a variety of different directions of differentiation, including gastric, intestinal, pancreatobiliary (PB), and oncocytic types. IPMNs can also harbor varying grades of architectural and cytologic atypia. IPMNs confined to branch ducts are mostly the gastric type, and IPMNs involving the main ducts are often intestinal type, while PB and oncocytic types are rare. Small (< 1 cm) IPMNs of the gastric type are not always morphologically distinguishable from low-grade PanINs. Mucin expression profiles suggest intestinal-type IPMNs progress to mucinous noncystic (colloid) carcinoma, while PB-type IPMNs progress toward ductal adenocarcinoma. It is a well-described paradigm that PanIN lesions progress toward ductal adenocarcinoma through step-wise genetic alterations. The activation of Hedgehog and Notch signaling pathways in PanIN lesions as well as in pancreatic adenocarcinoma suggest that developmental pathways may be disregulated during carcinogenesis of the pancreas. Further study is needed to elucidate the pathways from precursors toward invasive carcinoma of the pancreas.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 50 条
  • [31] Current Screening Strategies for Pancreatic Cancer
    Vanek, Petr
    Urban, Ondrej
    Zoundjiekpon, Vincent
    Falt, Premysl
    BIOMEDICINES, 2022, 10 (09)
  • [32] Current Pathology Model of Pancreatic Cancer
    Szymonski, Krzysztof
    Milian-Ciesielska, Katarzyna
    Lipiec, Ewelina
    Adamek, Dariusz
    CANCERS, 2022, 14 (09)
  • [33] Current status of surgery for pancreatic cancer
    Hirata, Koichi
    Egawa, Shinichi
    Kimura, Yasutoshi
    Nobuoka, Takayuki
    Oshima, Hidenori
    Katsuramaki, Tadashi
    Mizuguchi, Toru
    Furuhata, Tomohisa
    DIGESTIVE SURGERY, 2007, 24 (02) : 137 - 147
  • [34] Current and emerging treatments for pancreatic cancer
    Regine, WF
    John, WJ
    Mohiuddin, M
    DRUGS & AGING, 1997, 11 (04) : 285 - 295
  • [35] Current surgical management of pancreatic cancer
    Kim, Charles B.
    Ahmed, Shuja
    Hsueh, Eddy C.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2011, 2 (03) : 126 - 135
  • [36] Immunotherapy for pancreatic cancer:: current concepts
    Kaufman, HL
    Di Vito, J
    Hörig, H
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (01) : 159 - +
  • [37] Pancreatic cancer microenvironment: a current dilemma
    Uzunparmak, Burak
    Sahin, Ibrahim Halil
    CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
  • [38] Current status of pancreatic cancer with oligometastasis
    Chapa-Azuela, Oscar
    Corona-Torres, Maria J.
    Ayala-Moreno, Edwin A.
    Arroyo-Paredes, Paola S.
    Perez-Torres, Eduardo
    Rodriguez-Baez, Alejandro
    Montalvo-Jave, Eduardo E.
    CIRUGIA Y CIRUJANOS, 2023, 91 (02): : 262 - 267
  • [39] Familial Pancreatic Cancer: Current Perspectives
    Llach, Joan
    Carballal, Sabela
    Moreira, Leticia
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 743 - 758
  • [40] Current progress in immunotherapy for pancreatic cancer
    Foley, Kelly
    Kim, Victoria
    Jaffee, Elizabeth
    Zheng, Lei
    CANCER LETTERS, 2016, 381 (01) : 244 - 251